Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
How do you interpret the financial data for November?

Road to Rate Cuts Hits "Roadblock": Hawkish Pressure Builds Inside the Fed, 2026 Roadmap Stuck in Limbo

Trump may significantly relax marijuana restrictions, causing marijuana stocks to soar.
How do you interpret the financial data for November?
Road to Rate Cuts Hits "Roadblock": Hawkish Pressure Builds Inside the Fed, 2026 Roadmap Stuck in Limbo

Trump may significantly relax marijuana restrictions, causing marijuana stocks to soar.

RECOMMEND

Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025

Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025

Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025


